These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
540 related items for PubMed ID: 26528863
21. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis. Tortelli R, Copetti M, Ruggieri M, Cortese R, Capozzo R, Leo A, D'Errico E, Mastrapasqua M, Zoccolella S, Pellegrini F, Simone IL, Logroscino G. Eur J Neurol; 2015 Jan; 22(1):215-8. PubMed ID: 24750431 [Abstract] [Full Text] [Related]
22. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. De Schaepdryver M, Jeromin A, Gille B, Claeys KG, Herbst V, Brix B, Van Damme P, Poesen K. J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919 [Abstract] [Full Text] [Related]
23. Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. McCombe PA, Pfluger C, Singh P, Lim CY, Airey C, Henderson RD. J Neurol Sci; 2015 Apr; 353(1-2):122-9. PubMed ID: 25958264 [Abstract] [Full Text] [Related]
24. Axonal damage markers in cerebrospinal fluid are increased in ALS. Brettschneider J, Petzold A, Süssmuth SD, Ludolph AC, Tumani H. Neurology; 2006 Mar 28; 66(6):852-6. PubMed ID: 16567701 [Abstract] [Full Text] [Related]
25. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study. Zucchi E, Bedin R, Fasano A, Fini N, Gessani A, Vinceti M, Mandrioli J. Neurodegener Dis; 2018 Mar 28; 18(5-6):255-261. PubMed ID: 30428468 [Abstract] [Full Text] [Related]
38. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis. Steinacker P, Fang L, Kuhle J, Petzold A, Tumani H, Ludolph AC, Otto M, Brettschneider J. PLoS One; 2011 Sep 25; 6(8):e23600. PubMed ID: 21858182 [Abstract] [Full Text] [Related]
39. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, Bowser R. J Neurochem; 2011 May 25; 117(3):528-37. PubMed ID: 21418221 [Abstract] [Full Text] [Related]